ArticleMolecular therapy. Methods & clinical development2025

Nonclinical toxicity study duration in AAV gene therapy development: Evidence from industry survey supports adequacy of short-term assessments.

Basel T Assaf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.